Skip to content

Harm-reduction information only — not medical advice. In crisis or experiencing adverse effects, contact a healthcare professional or your local emergency services immediately.

AnabolicPlotter logo AnabolicPlotter
Search (no-JS fallback)
Anabolic Steroids/Hormones Human RCT evidence

Testosterone Enanthate

Test E · TE · Test Enth

7.2 days
Half-life
100–600 mg
Typical dose
2×/week
Frequency
TRT ongoing / cycles 10–16 weeks
Cycle length

Long-acting testosterone ester; the most common TRT and cycle base. Reaches steady state in ~5 weeks.

Key takeaways

  • The most common TRT and cycle-base ester — ~7-day half-life, steady state in about 5 weeks.
  • Twice-weekly injection smooths peaks and troughs and reduces estradiol/hematocrit excursions vs once-weekly.
  • Aromatizes to estradiol; monitor E2, hematocrit, PSA, and lipids throughout use.
  • Full HPTA suppression is rapid — any non-TRT cycle needs a structured PCT planned in advance.

Overview

What it is

Testosterone enanthate is a long-acting injectable testosterone ester and the most common base compound in both clinical TRT and non-medical cycles. Tissue esterases cleave the ester after injection, releasing free testosterone that binds the androgen receptor and drives protein synthesis, nitrogen retention, and erythropoiesis.

Pharmacokinetics

Its 7.19-day half-life gives a serum peak around 1.4 days post-injection and roughly 5 weeks to steady state, which is why twice-weekly injection is the common schedule — it smooths the peak-to-trough swing.

Harm reduction

It aromatizes readily to estradiol and 5-alpha-reduces to DHT, so the core monitoring set is estradiol, hematocrit, PSA, and lipids. HPTA suppression is complete and rapid, so any non-TRT use needs a structured PCT. It is not hepatotoxic since it bypasses first-pass metabolism.

Reported dosing protocols

Protocols reported in research literature and clinic/community use — informational context, not a dosing recommendation.

Use case Dose Route Frequency Duration
TRT (clinical) 75–100 mg weekly (or 150–200 mg q2wk) IM 1–2× weekly Ongoing
Performance (community) 300–600 mg weekly IM 2× weekly 10–16 weeks

Pharmacokinetic summary

Model tier
Linear Regression (sublinear dose)
Half-life
7.2 days
Cmax
1122 ng/dL
Tmax
1.4 days
Bioavailability
72%
Typical dose
100–600 mg

Harm reduction

Aromatizes
Yes
DHT derivative
No
Injection frequency
2×/week
Bloodwork range
300–1000 ng/dL

Frequently asked questions

Enanthate vs cypionate — what's the difference?

Almost nothing practical. Cypionate carries one extra ester carbon and a marginally longer tail (~8 vs ~7 days half-life). Schedules and blood levels are effectively interchangeable; enanthate dominates outside the US, cypionate within it.

How long until testosterone enanthate reaches steady levels?

About 5 weeks at a stable schedule, roughly five half-lives. Levels peak around 1.4 days after each injection and decline over the following week, which is why the weekly dose is usually split rather than given all at once.

Do you need PCT after a testosterone enanthate cycle?

Yes for any non-TRT use. Exogenous testosterone fully suppresses the HPTA within weeks. PCT (typically SERMs) starts only after the ester clears — with a ~7-day half-life, that means waiting roughly 2–3 weeks after the last injection.

References

Related articles

Related compounds

Protocols featuring Testosterone Enanthate

Comments

Loading comments…